• Tue news: Regeneron fails to block Eylea biosimilar. Inside the GLP-1 price war. Novartis inks $1B biobucks deal. UCB/Biogen lupus drug. Lilly Alzheimer’s drug approved in Japan. See more on our front page

Lastacaft off UHC July 31st

Anonymous

Guest
Just got word from a friend in managed care that lastacaft will be covered on UHC until July 31st because of the 6 month exemption in coverage. After that, the next review of the class won't be until Oct, Nov time frame. Be careful what you say to doctors about lastacaft coverage on UHC because it is temporary. The only drugs that will be exclusive to UHC after July 31st is Bepreve and generics. Don't shoot yourselves in the foot. It happens to all the new products with UHC after 6 months.
 

<











Just got word from a friend in managed care that lastacaft will be covered on UHC until July 31st because of the 6 month exemption in coverage. After that, the next review of the class won't be until Oct, Nov time frame. Be careful what you say to doctors about lastacaft coverage on UHC because it is temporary. The only drugs that will be exclusive to UHC after July 31st is Bepreve and generics. Don't shoot yourselves in the foot. It happens to all the new products with UHC after 6 months.

Go back to your own board Ista rep. You are just desperate because Bromday is a huge bust. Who would want to pay 10x the price of a generic xibrom to get half as much? NOBODY!